Hyperkalemia Updates on Outcomes and Therapeutic Strategies

Overview

Hyperkalemia is a frequent abnormality seen in patients with chronic kidney disease and is associated with a higher risk of mortality and malignant arrhythmias. Over the last few years, the development of novel potassium binders has ushered in a new era of hyperkalemia management while maintaining the use of beneficial medications such as renin-angiotensin-aldosterone system inhibitors. Join us in this informative session to learn more about updates on outcomes and therapeutic strategies.